Registry for Advanced Endoscopy
ERDB
Research Registry for Endoscopic Treatment and Diagnostics
1 other identifier
observational
1,000
1 country
1
Brief Summary
Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedStudy Start
First participant enrolled
January 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 14, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 14, 2032
April 12, 2024
April 1, 2024
10 years
December 25, 2021
April 11, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Adverse events
Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event
30-days and 60-days post-procedure
Diagnostic yield
Diagnostic yield after tissue sampling
1-year follow up
Interventions
Endoscopic intervention in the biliary or pancreatic duct
Endoscopic investigation/intervention with ultrasound
Eligibility Criteria
Patients eligible for endoscopic procedures at Karolinska University Hospital
You may qualify if:
- Clinical indication for endoscopic intervention/procedure
You may not qualify if:
- No informed consent
- Age \<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Stockholmlead
- Karolinska Institutetcollaborator
Study Sites (1)
Karolinska University Hospital
Stockholm, 18146, Sweden
Biospecimen
Whole blood, serum, plasma, bile, tissue samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erik von Seth, MD, PhD
Region Stockholm
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 25, 2021
First Posted
January 11, 2022
Study Start
January 14, 2022
Primary Completion (Estimated)
January 14, 2032
Study Completion (Estimated)
January 14, 2032
Last Updated
April 12, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share